VGM & ASSOCIATESHealthcare MSO

CMS Reevaluates Accelerated Payment Program And Suspends Advance Payment Program

Published in Member Communities on April 27, 2020

An Accelerated/Advance Payment is intended to provide necessary funds when there is an interruption in claim submission. The expedited payments are offered in circumstances including natural disasters or national emergences, such as the COVID-19 pandemic. The temporary loan programs are available to both Part A and Part B providers/suppliers as resource to assist with cash flow disruptions.  
 
Effective April 26th, 2020, CMS will not be accepting any new applications for the Advance Payment Program and will be reevaluating all pending and new applications for the Accelerated Payment Program. Currently, suspension for the Advance Payment Program applies to Part B suppliers.
 
According to the release by CMS, “Since expanding the programs on March 28, 2020, CMS approved over 21,000 applications totaling $59.6 billion in payments to Part A providers, which includes hospitals. For Part B suppliers, including doctors, non-physician practitioners and durable medical equipment suppliers, CMS approved almost 24,000 applications advancing $40.4 billion in payments.”

While the Advance Payment Program may be suspended for suppliers, there are still other opportunities available for funding. Stay tuned for further updates. For any questions related to the Accelerated/Advance Payment Program, please reach out to Ronda Buhrmester at ronda.buhrmester@vgm.com or via phone/text at 217-493-5440.

Get Connected

Stay up-to-date on the latest resources and news provided by VGM & Associates.

Sign Up for Email

From Our Experts

Customization, Communication, and Clinical Strength: The Indie Edge in Complex Rehab thumbnail Customization, Communication, and Clinical Strength: The Indie Edge in Complex Rehab Independent complex rehab providers say they are differentiating themselves with product customization and referral and patient engagement. The Rising Cost of Doing Business in the Mobility and Complex Rehab Technology Industry thumbnail The Rising Cost of Doing Business in the Mobility and Complex Rehab Technology Industry This article delves into concerns of rising costs in the mobility and complex rehab technology (CRT) industry and explores potential strategies to mitigate their impact. Empowering Patients and Caregivers: Advocacy and Education thumbnail Empowering Patients and Caregivers: Advocacy and Education Whether it's a safety bed, mobility aid, or a respiratory device, healthcare providers' roles extend beyond equipment delivery—we are educators, advocates, and allies. Staffing Ratios and Compensation Insights for U.S. Rehab Members and CRT Dealers thumbnail Staffing Ratios and Compensation Insights for U.S. Rehab Members and CRT Dealers This report provides insights into team structures and pay for key roles like ATPs, service technicians, and billing personnel. Marketing: Embrace the Happy Customer thumbnail Marketing: Embrace the Happy Customer In today's hyper-connected world, customer satisfaction isn't just a metric—it's a marketing engine. A Letter From the President: July 2025 thumbnail A Letter From the President: July 2025 From evolving reimbursement models to the complexities of competitive bidding, the landscape continues to shift beneath our feet, but VGM is here for you. How the June 2025 MedPAC Report Shapes the Future of HME thumbnail How the June 2025 MedPAC Report Shapes the Future of HME The June 2025 Report to Congress from the Medicare Payment Advisory Commission (MedPAC) offers critical insights into the evolving landscape of Medicare services. While the report does not focus exclusively on home medical equipment (HME) or durable medical equipment (DME), several areas touch on themes that are highly relevant to the industry's future—particularly around home health care, Medicare Advantage (MA), and supplemental benefits. Navigating the New CMS Landscape with the HMV and RAD Decision Memo for COPD thumbnail Navigating the New CMS Landscape with the HMV and RAD Decision Memo for COPD Ronda Buhrmester, Sr. Director of Payer Relations and Reimbursement, shares insights on the newly finalized National Coverage Determination (NCD) for home mechanical ventilation (HMV) and respiratory assist devices (RAD).

Give your business an advantage over the competition.

Become a Member